{"schema_version":"1","generated_at":"2026-11-17T14:57:24.215Z","data_as_of":"2026-11-13","url":"https://www.findmykol.com/kol/jimmitti-teysir","json_url":"https://www.findmykol.com/kol/jimmitti-teysir/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"jimmitti-teysir","name":"Jimmitti Teysir","credential":"MD","title":"Breast Medical Oncologist","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Breast","therapeutic_areas":["Breast","Lung","Oncology"],"institution":"Memorial Sloan Kettering Cancer Center","institution_url":"https://www.findmykol.com/institution/memorial-sloan-kettering-cancer-center","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1629605233","orcid":"0000-0003-1334-0701","openalex":"A5063300116"},"summary":"Jimmitti Teysir is Breast Medical Oncologist at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 16 publications with 608 citations (h-index 6).","overview":{"text":"Jimmitti Teysir, MD, is Breast Medical Oncologist at Memorial Sloan Kettering Cancer Center. The public record shows 16 publications with 608 citations (h-index 6), centered on Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Advanced Breast Cancer Therapies. It also documents industry payments reported by 2 companies.","bullets":["Top research focus: Cancer Genomics and Diagnostics","Open Payments reporting from 2 companies"],"generated_at":"2026-11-17"},"focus":{"indications":[{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Cancer Genomics and Diagnostics","Cancer Immunotherapy and Biomarkers","Advanced Breast Cancer Therapies","Breast Cancer Treatment Studies","Lung Cancer Treatments and Mutations"],"drugs_studied":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Itovebi","generic":"Inavolisib","trials":0,"payments":2,"publications":1,"mentions":3}]},"works_with":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Genentech USA, Inc.","trials":0,"payments":1,"mentions":1},{"name":"Genentech, Inc.","trials":0,"payments":1,"mentions":1}]}},"scholarship":{"works_count":16,"cited_by_count":608,"h_index":6,"i10_index":5,"pubmed_count":2,"latest_activity_year":2025,"emerging":true,"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2025,"last":2025},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":154.44,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629605233"},{"payer":"Genentech, Inc.","program_year":2025,"amount_usd":150.94,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1629605233"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1629605233","source":"payments"},"prescribing":{"data_year":2022,"areas_total":2,"areas_shown":2,"areas":[{"area":"Nervous system","share_pct":61.3,"classes_total":1,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":61.3,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":38.7,"classes_total":1,"classes":[{"class":"Statin","setting":"prescribed","share_pct":38.7,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":4,"years":{"first":2025,"last":2026},"societies":["ASCO"],"shown":3,"withheld":1,"rows":[{"title":"Characterization of inavolisib-associated hyperglycemia in metastatic hormone receptor–positive (HR+) breast cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e13055","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e13055","status":"verified"},{"title":"Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC).","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.1011","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.1011","status":"verified"},{"title":"Treatment patterns in HR+/HER2- metastatic breast cancer (MBC) with co-occurring PIK3CA and ESR1 mutations.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.1082","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.1082","status":"verified"}],"source":"congress"},"publications":{"total":2,"shown":5,"withheld":11,"matched_by":"OpenAlex author record","recent":[{"title":"Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive metastatic breast cancer","year":2026,"journal":"Breast Cancer Research","source_url":"https://doi.org/10.1186/s13058-025-02152-0","status":"verified"},{"title":"Characterization of inavolisib-associated hyperglycemia in metastatic hormone receptor–positive (HR+) breast cancer.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e13055","status":"verified"},{"title":"Abstract PS1-11-23: Clinicogenomic Features of Recurrence After Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps1-11-23","status":"verified"},{"title":"After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor–Positive Metastatic Breast Cancer","year":2025,"journal":"American Society of Clinical Oncology Educational Book","source_url":"https://doi.org/10.1200/edbk-25-473372","status":"verified"},{"title":"Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC).","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.1011","status":"verified"}],"most_cited":{"total":16,"shown":5,"withheld":11,"rows":[{"title":"Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA","year":2018,"cited_by_count":456,"type":"article","source_url":"https://doi.org/10.1158/1078-0432.ccr-17-1341"},{"title":"Depression, Anxiety, Post-traumatic Stress Disorder and a History of Pervasive Gender-Based Violence Among Women Asylum Seekers Who Have Undergone Female Genital Mutilation/Cutting: A Retrospective Case Review","year":2018,"cited_by_count":71,"type":"article","source_url":"https://doi.org/10.1007/s10903-018-0782-x"},{"title":"Disparities in osteoporosis care among postmenopausal women in the United States","year":2021,"cited_by_count":40,"type":"review","source_url":"https://doi.org/10.1016/j.maturitas.2021.10.010"},{"title":"After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor–Positive Metastatic Breast Cancer","year":2025,"cited_by_count":15,"type":"review","source_url":"https://doi.org/10.1200/edbk-25-473372"},{"title":"Racial disparities in surveillance mammography among older breast cancer survivors","year":2019,"cited_by_count":15,"type":"article","source_url":"https://doi.org/10.1007/s10549-019-05250-8"}]},"source":"works"},"network":{"coauthors_total":38,"shown":3,"withheld":35,"coauthors":[{"name":"Komal L. Jhaveri","coauthored_works":6},{"name":"Pedram Razavi","coauthored_works":5,"profile_url":"https://www.findmykol.com/kol/pedram-razavi"},{"name":"Sherry Shen","coauthored_works":3,"profile_url":"https://www.findmykol.com/kol/sherry-shen"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/jimmitti-teysir-md","status":"verified"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://www.mskcc.org/cancer-care/doctors/jimmitti-teysir","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, Icahn School of Medicine at Mount Sinai","source_url":"https://www.mskcc.org/cancer-care/doctors/jimmitti-teysir","status":"verified","collected_at":"2026-11-13"},{"value":"BA, Yale University","source_url":"https://www.mskcc.org/cancer-care/doctors/jimmitti-teysir","status":"verified","collected_at":"2026-11-13"}]},"awards":{"total":4,"shown":3,"rows":[{"value":"Young Investigator Award, Conquer Cancer Foundation (2025)","source_url":"https://www.mskcc.org/cancer-care/doctors/jimmitti-teysir","status":"verified","collected_at":"2026-11-13"},{"value":"T32 Hematology–Oncology Research Training Grant Fellow, National Cancer Institute (NCI)/Memorial Sloan Kettering Cancer Center (2024–2025)","source_url":"https://www.mskcc.org/cancer-care/doctors/jimmitti-teysir","status":"verified","collected_at":"2026-11-13"},{"value":"Conquer Cancer Vaniam Group LLC Young Investigator Award (2025 honoree)","source_url":"https://womenleadersinoncology.com/?p=1489","status":"provisional","collected_at":"2026-11-13"}]}},"similar":[{"name":"Marc Ladanyi","slug":"marc-ladanyi","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Anatomic Pathology","url":"https://www.findmykol.com/kol/marc-ladanyi","json_url":"https://www.findmykol.com/kol/marc-ladanyi/profile.json"},{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Murray Brennan","slug":"murray-brennan","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/murray-brennan","json_url":"https://www.findmykol.com/kol/murray-brennan/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Hope Rugo","slug":"hope-rugo","institution":"City of Hope","specialty":"Hematology","url":"https://www.findmykol.com/kol/hope-rugo","json_url":"https://www.findmykol.com/kol/hope-rugo/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":1,"publications":11,"network":35}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-13"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2025 to 2025","collected_at":"2026-11-13"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-13"}},"methodology_url":"https://www.findmykol.com/about#methodology"}